Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
89.9 EUR | +1.12% | +1.08% | -3.47% |
Mar. 26 | Mib rises to 34,700; Iveco at annual high | AN |
Mar. 26 | Mib still bullish; Rai Way bullish after accounts | AN |
Business Summary
At the end of 2022, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.
Number of employees: 3,365
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Diagnostic Kits
100.0
%
| 1,238 | 100.0 % | 1,361 | 100.0 % | +9.98% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
North America
57.5
%
| 604 | 48.8 % | 783 | 57.5 % | +29.51% |
Europe
19.8
%
| 285 | 23.0 % | 269 | 19.8 % | -5.55% |
Italy
14.5
%
| 229 | 18.5 % | 198 | 14.5 % | -13.66% |
Rest of the World
8.2
%
| 119 | 9.6 % | 112 | 8.2 % | -6.54% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Carlo Rosa
CEO | Chief Executive Officer | 58 | 97-12-31 |
Director of Finance/CFO | 53 | 10-12-31 | |
Director/Board Member | 61 | 99-12-31 | |
Riccardo Fava
IRC | Investor Relations Contact | - | - |
Stefano Ronchi
HRO | Human Resources Officer | 64 | 06-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 22-04-28 | |
Michele Denegri
CHM | Chairman | 55 | 07-03-25 |
Carlo Rosa
CEO | Chief Executive Officer | 58 | 97-12-31 |
Director/Board Member | 61 | 99-12-31 | |
Franco Moscetti
BRD | Director/Board Member | 72 | 07-03-25 |
Director/Board Member | 84 | 16-04-27 | |
Diego Pistone
BRD | Director/Board Member | 73 | 22-04-28 |
Roberta Somati
BRD | Director/Board Member | 55 | 13-04-21 |
Stefano Altara
BRD | Director/Board Member | 56 | 14-04-22 |
Director/Board Member | 64 | 16-04-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 55,948,257 | 21,096,501 ( 37.71 %) | 2,659,129 ( 4.753 %) | 37.71 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
DIASORIN S.P.A. 4.86% | 2,716,663 | 4.86% | 274,521,947 $ |
IMPEDIMED LIMITED 0.66% | 13,300,000 | 0.66% | 718,865 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Luminex Molecular Diagnostics, Inc.
Luminex Molecular Diagnostics, Inc. Medical/Nursing ServicesHealth Services Luminex Molecular Diagnostics, Inc. develops DNA based diagnostics tests and software solutions, which include genetic tests for disorders, drug metabolism and infectious diseases. The firm’s products include P450-2D6, P450-2C9, P450-2C19, AJ panel and CFTR. The company was founded in March 2007 and is headquartered in Toronto, Canada. |
Medical/Nursing Services
|
Diasorin, Inc.
Diasorin, Inc. Medical SpecialtiesHealth Technology Diasorin, Inc. develops and manufactures reagents for in vitro diagnostics. It has products in the fields of infectious disease, hepatitis, endocrinology, bone and mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The company was founded in 1975 and is headquartered in Stillwater, MN. |
Medical Specialties
|
Diasorin Italia SpA
|
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.64% | 5.13B | |
+0.40% | 12.93B | |
-4.69% | 8.1B | |
+2.96% | 4.72B | |
-34.08% | 4.4B | |
-2.48% | 4.14B | |
+15.50% | 2.82B | |
+2.31% | 2.55B | |
+11.81% | 1.92B | |
-1.77% | 1.65B |
- Stock
- Equities
- Stock DiaSorin S.p.A. - Borsa Italiana
- Company DiaSorin S.p.A.